{"id":160887,"name":"BLOOD CANCER UNITED (FKA THE LEUKEMIA & LYMPHOMA SOCIETY)","slug":"blood-cancer-united-fka-the-leukemia-lymphoma-society","state":"DC","country":"United States of America","description":"","totalSpending":6800000,"filings":32,"yearlySpending":[{"year":2018,"income":405000},{"year":2019,"income":490000},{"year":2020,"income":420000},{"year":2021,"income":635000},{"year":2022,"income":700000},{"year":2023,"income":1200000},{"year":2024,"income":1010000},{"year":2025,"income":1940000}],"issues":["MMM","BUD","HCR","EDU","TAX","UNM","FIN","MED"],"firms":["BLOOD CANCER UNITED (FKA THE LEUKEMIA & LYMPHOMA SOCIETY)"],"lobbyists":["BRIAN CONNELL","SARAH MILBERG","KATIE BERGE","MATTHEW MARKS","BEVERLY HART","JESSICA BURNELL"],"govEntities":["Centers For Medicare and Medicaid Services (CMS)","HOUSE OF REPRESENTATIVES","Natl Institutes of Health (NIH)","SENATE","Health & Human Services, Dept of (HHS)","Food & Drug Administration (FDA)","Office of Management & Budget (OMB)","White House Office","Executive Office of the President (EOP)","Labor, Dept of (DOL)","Treasury, Dept of"],"sampleDescriptions":["Medicare Part D plan benefit design and out-of-pocket costs; Part D protected classes protection","Fiscal Year 2018 National Institutes of Health appropriations; Fiscal Year 2019 National Institutes of Health appropriations; Fiscal Year 2018 Department of Defense appropriations; Fiscal Year 2019 De","Cancer Drug Parity Act (HR 1409, Senate bill not yet introduced); the Right to Try Act (S 204, HR 878); the Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 20","Medicare Part D plan benefit design and out-of-pocket costs","The Deferment for Active Cancer Treatment Act (HR 2976/S 3207)"],"years":[2018,2019,2020,2021,2022,2023,2024,2025]}